SAN DIEGO and SALT LAKE CITY, Aug. 9, 2013 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP is investigating claims on behalf of investors in USANA Health Sciences, Inc. (NYSE: USNA) ("USANA Health"). USANA Health develops, manufactures, distributes, and sells nutritional and personal care products worldwide.
USANA Health Investigated by the Securities and Exchange Commission for Possible Insider Trading
Robbins Arroyo's investigation concerns whether USANA Health's officers and directors breached their fiduciary duties. On July 23, 2014, USANA Health disclosed in a regulatory filing that the company is being investigated by the Securities and Exchange Commission ("SEC"). According to the company, the investigation appears to involve the trading of company securities by certain company directors, including the Chairman, during late 2012. During this time, based upon filings with the SEC, these directors sold approximately $45 million worth of their USANA Health stock.If you invested in USANA Health and would like to discuss your shareholder rights, please contact attorney Darnell R. Donahue at (800) 350-6003, firstname.lastname@example.org, or via the shareholder information form on the firm's website Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. For more information, please go to http://www.robbinsarroyo.com. Press release link: http://www.robbinsarroyo.com/shareholders-rights-blog/usana-health-sciences-inc/ Attorney Advertising. Past results do not guarantee a similar outcome. Contact: Darnell R. Donahue Robbins Arroyo LLP email@example.com (619) 525-3990 or Toll Free at (800) 350-6003 http://www.robbinsarroyo.com SOURCE Robbins Arroyo LLP
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts